Atlas Venture Fund XIV

About Atlas Venture Fund XIV

Atlas Venture Fund XIV is a venture capital firm based in United States, focusing on Pre-Seed stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionUnited States

Funding StagePre Seed

Industry Focus

Deep Tech

Saas

Investor Signals Profile

active

Sweet Spot

Biotech founders building high-value therapeutics with exit potential

biotech

therapeutics

life sciences

IPO-ready

M&A exits

Bullish Signals

Kailera IPO: $718.8M largest biotech everexternal

Day One acquired by Servier for $2.5Bexternal

Two major exits in same periodexternal

Atlas confirmed active on LinkedInlinkedin

Post edited 3d ago — fund postinglinkedin

Contrarian Signals

Biotech-only, narrow sector focusexternal

Founder Do's

Build for IPO or acquisition from day one

Focus on breakthrough therapeutics

Show large market potential

Founder Don'ts

Avoid non-life-sciences pitches

Don't pitch without clinical angle

Avoid incremental, low-exit-potential ideas

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$450M

Saves0

Website

Key People

Kevin Bitterman, Bruce Booth, Michael Gladstone